MAPT and Alzheimer disease: By using distinct HTN induction methods in two animal models, we demonstrated that HTN increases AD-related pathologies (hippocampal Aβ concentration, amyloid plaque load and p-tau level), induces shrinkage in dendritic complexity and microglial activation, and moderately impairs learning and memory.